304 related articles for article (PubMed ID: 16236521)
1. The molecular pathogenesis of acute myeloid leukemia.
Steffen B; Müller-Tidow C; Schwäble J; Berdel WE; Serve H
Crit Rev Oncol Hematol; 2005 Nov; 56(2):195-221. PubMed ID: 16236521
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
4. Targeting receptor tyrosine kinase signaling in acute myeloid leukemia.
Doepfner KT; Boller D; Arcaro A
Crit Rev Oncol Hematol; 2007 Sep; 63(3):215-30. PubMed ID: 17658267
[TBL] [Abstract][Full Text] [Related]
5. Lineage-specific transcription factor aberrations in AML.
Mueller BU; Pabst T
Cancer Treat Res; 2010; 145():109-25. PubMed ID: 20306248
[TBL] [Abstract][Full Text] [Related]
6. [Pathobiology of acute myeloid leukemia].
Christ O; Feuring-Buske M; Hiddemann W; Buske C
Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: new players in AML pathogenesis.
Nicoloso MS; Jasra B; Calin GA
Cancer Treat Res; 2010; 145():169-81. PubMed ID: 20306251
[No Abstract] [Full Text] [Related]
8. New agents for the treatment of acute myeloid leukemia.
Tallman MS
Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia and the Wnt pathway.
Eaves CJ; Humphries RK
N Engl J Med; 2010 Jun; 362(24):2326-7. PubMed ID: 20554989
[No Abstract] [Full Text] [Related]
10. Insight into the molecular pathogenesis of myeloid malignancies.
Haferlach T; Bacher U; Haferlach C; Kern W; Schnittger S
Curr Opin Hematol; 2007 Mar; 14(2):90-7. PubMed ID: 17255785
[TBL] [Abstract][Full Text] [Related]
11. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
12. Molecularly targeted therapy in acute myeloid leukemia.
Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Quarna J
Ann N Y Acad Sci; 2004 Dec; 1028():409-22. PubMed ID: 15650266
[TBL] [Abstract][Full Text] [Related]
13. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
Pabst T; Mueller BU
Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of signaling pathways in acute myeloid leukemia.
Scholl C; Gilliland DG; Fröhling S
Semin Oncol; 2008 Aug; 35(4):336-45. PubMed ID: 18692684
[TBL] [Abstract][Full Text] [Related]
15. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
16. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
17. Human TM9SF4 Is a New Gene Down-Regulated by Hypoxia and Involved in Cell Adhesion of Leukemic Cells.
Paolillo R; Spinello I; Quaranta MT; Pasquini L; Pelosi E; Lo Coco F; Testa U; Labbaye C
PLoS One; 2015; 10(5):e0126968. PubMed ID: 25961573
[TBL] [Abstract][Full Text] [Related]
18. The molecular biology of acute myeloid leukemia. Proto-oncogene expression and function in normal and neoplastic myeloid cells.
Willman CL; Whittaker MH
Clin Lab Med; 1990 Dec; 10(4):769-96. PubMed ID: 2176959
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
[TBL] [Abstract][Full Text] [Related]
20. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
